A detailed history of Dafna Capital Management LLC transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Dafna Capital Management LLC holds 517,994 shares of RVMD stock, worth $22.4 Million. This represents 6.03% of its overall portfolio holdings.

Number of Shares
517,994
Previous 511,894 1.19%
Holding current value
$22.4 Million
Previous $19.9 Million 18.14%
% of portfolio
6.03%
Previous 5.09%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$36.92 - $47.94 $225,212 - $292,434
6,100 Added 1.19%
517,994 $23.5 Million
Q4 2023

Feb 14, 2024

BUY
$18.35 - $34.12 $706,475 - $1.31 Million
38,500 Added 8.13%
511,894 $14.7 Million
Q3 2023

Nov 14, 2023

SELL
$25.17 - $35.05 $978,886 - $1.36 Million
-38,891 Reduced 7.59%
473,394 $13.1 Million
Q2 2023

Aug 14, 2023

SELL
$20.28 - $27.0 $1.29 Million - $1.71 Million
-63,500 Reduced 11.03%
512,285 $13.7 Million
Q1 2023

May 15, 2023

BUY
$20.76 - $30.09 $2.03 Million - $2.95 Million
98,000 Added 20.51%
575,785 $12.5 Million
Q4 2022

Feb 14, 2023

SELL
$17.68 - $25.53 $35,360 - $51,060
-2,000 Reduced 0.42%
477,785 $11.4 Million
Q3 2022

Nov 14, 2022

BUY
$17.46 - $26.0 $3.14 Million - $4.68 Million
180,000 Added 60.04%
479,785 $9.46 Million
Q2 2022

Aug 15, 2022

BUY
$14.54 - $27.17 $984,125 - $1.84 Million
67,684 Added 29.16%
299,785 $5.84 Million
Q1 2022

May 16, 2022

BUY
$17.31 - $26.4 $343,949 - $524,568
19,870 Added 9.36%
232,101 $5.92 Million
Q4 2021

Feb 14, 2022

BUY
$24.35 - $33.7 $60,875 - $84,250
2,500 Added 1.19%
212,231 $5.34 Million
Q2 2021

Aug 16, 2021

BUY
$29.0 - $47.44 $1.7 Million - $2.78 Million
58,500 Added 38.68%
209,731 $6.66 Million
Q1 2021

May 17, 2021

BUY
$37.21 - $54.43 $4.79 Million - $7.01 Million
128,731 Added 572.14%
151,231 $6.94 Million
Q4 2020

Feb 16, 2021

BUY
$30.19 - $45.49 $679,275 - $1.02 Million
22,500 New
22,500 $891,000

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.8B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Dafna Capital Management LLC Portfolio

Follow Dafna Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.